"Occult Blood" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Chemical, spectroscopic, or microscopic detection of extremely small amounts of blood.
| Descriptor ID |
D009780
|
| MeSH Number(s) |
E01.370.225.925 E05.200.925
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Occult Blood".
Below are MeSH descriptors whose meaning is more specific than "Occult Blood".
This graph shows the total number of publications written about "Occult Blood" by people in this website by year, and whether "Occult Blood" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 0 | 1 | 1 |
| 2004 | 0 | 1 | 1 |
| 2005 | 1 | 1 | 2 |
| 2006 | 0 | 2 | 2 |
| 2007 | 0 | 1 | 1 |
| 2009 | 2 | 0 | 2 |
| 2013 | 1 | 2 | 3 |
| 2016 | 1 | 0 | 1 |
| 2017 | 1 | 0 | 1 |
| 2021 | 0 | 3 | 3 |
| 2022 | 0 | 1 | 1 |
| 2024 | 1 | 1 | 2 |
| 2025 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Occult Blood" by people in Profiles.
-
Use and de-implementation of fecal occult blood tests in the acute care setting: a systematic review and meta-analysis. Int J Qual Health Care. 2025 Feb 15; 37(1).
-
Interval Advanced Adenomas and Neoplasia in Patients with Negative Colonoscopy Following Positive Stool-Based Colorectal Cancer Screening Test. Dig Dis Sci. 2025 Jan; 70(1):350-359.
-
Bundling Colorectal Cancer Screening Outreach with Screening for Social Risk in Federally Qualified Health Centers: A Stepped-Wedge Implementation-Effectiveness Study. J Gen Intern Med. 2024 05; 39(7):1188-1195.
-
Route to diagnosis of colorectal cancer and association with survival within the context of a bowel screening programme. Public Health. 2022 Oct; 211:53-61.
-
Combining the quantitative faecal immunochemical test and full blood count reliably rules out colorectal cancer in a symptomatic patient referral pathway. Int J Colorectal Dis. 2022 Feb; 37(2):457-466.
-
The role of faecal calprotectin in the identification of colorectal neoplasia in patients attending for screening colonoscopy. Colorectal Dis. 2022 02; 24(2):188-196.
-
Colorectal cancer screening in African Americans: are we following the guidelines? Cancer Causes Control. 2021 Sep; 32(9):943-951.
-
Lower morbidity and improved outcomes in patients with screen-detected colorectal cancer. Rev Esp Enferm Dig. 2017 06 26; 109(7):483-484.
-
A comparison of tumour and host prognostic factors in screen-detected vs nonscreen-detected colorectal cancer: a contemporaneous study. Colorectal Dis. 2016 Oct; 18(10):967-975.
-
Blood-based tests for colorectal cancer screening: do they threaten the survival of the FIT test? Dig Dis Sci. 2015 Mar; 60(3):664-71.